Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 1
1968 1
1970 1
1973 1
1974 1
1977 1
1979 2
1980 1
1981 2
1982 2
1983 4
1984 12
1985 8
1986 3
1987 15
1988 22
1989 18
1990 22
1991 34
1992 21
1993 25
1994 31
1995 29
1996 32
1997 36
1998 40
1999 42
2000 41
2001 40
2002 40
2003 48
2004 41
2005 44
2006 43
2007 48
2008 75
2009 59
2010 72
2011 83
2012 106
2013 97
2014 122
2015 132
2016 139
2017 136
2018 169
2019 199
2020 214
Text availability
Article attribute
Article type
Publication date

Search Results

2,098 results
Results by year
Filters applied: . Clear all
Page 1
Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms.
van Weelden G, Bobiński M, Okła K, van Weelden WJ, Romano A, Pijnenborg JMA. van Weelden G, et al. Mar Drugs. 2019 Jan 7;17(1):32. doi: 10.3390/md17010032. Mar Drugs. 2019. PMID: 30621045 Free PMC article. Review.
However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailability, and all known different pathways affected by fucoidan, in order to formulate fucoidans structure and activity in relatio …
However, the exact mechanism of action is currently unknown. Therefore, this review will address fucoidans structure, the bioavailabi …
Therapeutic Effects of Fucoidan: A Review on Recent Studies.
Luthuli S, Wu S, Cheng Y, Zheng X, Wu M, Tong H. Luthuli S, et al. Mar Drugs. 2019 Aug 21;17(9):487. doi: 10.3390/md17090487. Mar Drugs. 2019. PMID: 31438588 Free PMC article. Review.
Fucoidan is a polysaccharide largely made up of l-fucose and sulfate groups. Fucoidan is favorable worldwide, especially amongst the food and pharmaceutical industry as a consequence of its promising therapeutic effects. ...
Fucoidan is a polysaccharide largely made up of l-fucose and sulfate groups. Fucoidan is favorable worldwide, especially among
Therapies from Fucoidan: New Developments.
Fitton HJ, Stringer DS, Park AY, Karpiniec SN. Fitton HJ, et al. Mar Drugs. 2019 Oct 9;17(10):571. doi: 10.3390/md17100571. Mar Drugs. 2019. PMID: 31601041 Free PMC article. Review.
Since our last review in 2015, the study and use of fucoidan has extended in several research areas. Clinical use of fucoidan for the treatment of renal disease has become available and human safety studies have been undertaken on radiolabeled fucoidan for th …
Since our last review in 2015, the study and use of fucoidan has extended in several research areas. Clinical use of fucoidan
Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies.
Wang Y, Xing M, Cao Q, Ji A, Liang H, Song S. Wang Y, et al. Mar Drugs. 2019 Mar 20;17(3):183. doi: 10.3390/md17030183. Mar Drugs. 2019. PMID: 30897733 Free PMC article. Review.
Fucoidan is a polysaccharide that mainly consists of L-fucose and sulphate groups. ...We hope that this review can provide some theoretical basis and inspiration for the product development of fucoidan....
Fucoidan is a polysaccharide that mainly consists of L-fucose and sulphate groups. ...We hope that this review can provide some theor
The Pharmacokinetics of Fucoidan after Topical Application to Rats.
Pozharitskaya ON, Shikov AN, Obluchinskaya ED, Vuorela H. Pozharitskaya ON, et al. Mar Drugs. 2019 Dec 6;17(12):687. doi: 10.3390/md17120687. Mar Drugs. 2019. PMID: 31817687 Free PMC article.
The longest half-life for fucoidan was observed in plasma, then in striated muscle andskin. It was found that the pharmacokinetics of fucoidan after topical OF application was linear, inthe range of 50-150 mg/kg. ...Our results support the rationality of topicalappl …
The longest half-life for fucoidan was observed in plasma, then in striated muscle andskin. It was found that the pharmacokinetics of …
Possibilities of Fucoidan Utilization in the Development of Pharmaceutical Dosage Forms.
Citkowska A, Szekalska M, Winnicka K. Citkowska A, et al. Mar Drugs. 2019 Aug 5;17(8):458. doi: 10.3390/md17080458. Mar Drugs. 2019. PMID: 31387230 Free PMC article. Review.
The potential application of fucoidan in the pharmaceutical technology is also due to its ionic nature. ...Advantages and limitations of fucoidan utilization in the pharmaceutical technology were also discussed....
The potential application of fucoidan in the pharmaceutical technology is also due to its ionic nature. ...Advantages and limitations …
Fucoidan as a Potential Therapeutic for Major Blinding Diseases--A Hypothesis.
Klettner A. Klettner A. Mar Drugs. 2016 Feb 3;14(2):31. doi: 10.3390/md14020031. Mar Drugs. 2016. PMID: 26848666 Free PMC article. Review.
However, the possible usage of fucoidan in ophthalmological diseases has received little attention so far. In this review, biological activities of fucoidan that could be of interest regarding these diseases will be discussed....
However, the possible usage of fucoidan in ophthalmological diseases has received little attention so far. In this review, biological …
"Fucoidan, a natural biopolymer in cancer combating: From edible algae to nanocarrier tailoring".
Etman SM, Elnaggar YSR, Abdallah OY. Etman SM, et al. Int J Biol Macromol. 2020 Mar 15;147:799-808. doi: 10.1016/j.ijbiomac.2019.11.191. Epub 2019 Nov 23. Int J Biol Macromol. 2020. PMID: 31770552 Review.
Fucoidan is an edible algae that has long been used as part of east Asians' diet. ...Furthermore, multifaceted nanotechnological applications of fucoidan in cancer treatment were reviewed. Fucoidan nanoparticles with efficient drug loading and release had bee
Fucoidan is an edible algae that has long been used as part of east Asians' diet. ...Furthermore, multifaceted nanotechnological appl
Fucoidan Promotes Apoptosis and Inhibits EMT of Breast Cancer Cells.
He X, Xue M, Jiang S, Li W, Yu J, Xiang S. He X, et al. Biol Pharm Bull. 2019;42(3):442-447. doi: 10.1248/bpb.b18-00777. Biol Pharm Bull. 2019. PMID: 30828076 Free article.
Fucoidan is an active component of seaweed, and could inhibit proliferation and induce apoptotic cell death in several tumor cells. However, the function of fucoidan in breast cancer is largely unknown. In the present study, we evaluated the anti-cancer potential of
Fucoidan is an active component of seaweed, and could inhibit proliferation and induce apoptotic cell death in several tumor cells. H
Current Designs and Developments of Fucoidan-based Formulations for Cancer Therapy.
Tran PHL, Tran TTD. Tran PHL, et al. Curr Drug Metab. 2019;20(12):933-941. doi: 10.2174/1389200220666191007154723. Curr Drug Metab. 2019. PMID: 31589118 Review.
RESULTS: Although the uniqueness, structure, properties, and health benefits of fucoidan have been mentioned in various prominent reviews, current developments and designs of fucoidan-based formulations still need to be assessed to further develop an effective antic …
RESULTS: Although the uniqueness, structure, properties, and health benefits of fucoidan have been mentioned in various prominent rev …
2,098 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback